Enhancement of Estrogen Receptor Transcriptional Activity by the Coactivator GRIP-1 Highlights the Role of Activation Function 2 in Determining Estrogen Receptor Pharmacology
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The human estrogen receptor (ER) contains two major activation functions (AFs) responsible for its transcriptional activity. One of these, activation function 2 (AF-2), located within the hormone-binding domain (HBD), has been shown to mediate the ligand-dependent transcriptional activity of ER as well as other members of the nuclear receptor superfamily. Recently, proteins interacting with the HBD of several nuclear receptors have been cloned. One of these proteins, glucocorticoid receptor interacting protein (GRIP-1), has been shown to interact with ER and was originally hypothesized to mediate its transcriptional activity through AF-2. However, we find in this study that the transcriptional activity of ER, containing mutations in the AF-2 core sequence, can be enhanced by coexpression of the coactivator GRIP-1, suggesting that this protein may not rely solely on the AF-2 domain for interaction. We propose, therefore, that the HBD of ER either contains multiple binding sites that are necessary for association with GRIP-1 or, alternatively, that this coactivator contacts the receptor in an undetermined region within the HBD. Importantly, these studies demonstrate also that mutations or deletion of AF-2 alter the ligand pharmacology of the receptor such that ER loses the ability to discriminate between agonists and antagonists. Interestingly, on these mutant receptors GRIP-1 still functions as a coactivator independent of the nature of the bound ligand. It is likely, therefore, that the C-terminal AF-2 domain may function as a molecular switch allowing the wild-type receptor to discriminate between agonists and antagonists as well as providing a surface with which associated proteins can interact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Nuclear protein CBP is a coactivator for the transcription factor CREB
Kwok, R. P. S., Lundblad, J. R., Chrivia, J. C., Richards, J. P., Bächinger, H. P., Brennan, R. G., Roberts, S. G. E., Green, M. R., & Goodman, R. H. (1994) · Nature · doi:10.1038/370223a0 · Cited by 1,443
Cited by
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Structure and specificity of nuclear receptor–coactivator interactions
Darimont, B. D., Wagner, R. L., Apriletti, J. W., Stallcup, M. R., Kushner, P. J., Baxter, J. D., Fletterick, R. J., & Yamamoto, K. R. (1998) · Genes & Development · doi:10.1101/gad.12.21.3343 · Cited by 924
Self-citationEstrogen receptor interaction with co-activators and co-repressors☆
Klinge, C. M. (2000) · Steroids · doi:10.1016/s0039-128x(99)00107-5 · Cited by 491
He, B., Kemppainen, J. A., & Wilson, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002807200 · Cited by 442
AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor
Font de Mora, J., & Brown, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5041-5047.2000 · Cited by 432
Wijayaratne, A. L., & McDonnell, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101097200 · Cited by 427
Self-citationEstrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β
Paige, L. A., Christensen, D. J., Grøn, H., Norris, J. D., Gottlin, E. B., Padilla, K. M., Chang, C.-Y., Ballas, L. M., Hamilton, P. T., McDonnell, D. P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3999 · Cited by 412
Self-citationEstrogen Receptor Mutations in Human Disease
Herynk, M. H., & Fuqua, S. A. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0010 · Cited by 400
He, B., Kemppainen, J. A., Voegel, J. J., Gronemeyer, H., & Wilson, E. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37219 · Cited by 372
Chang, C.-Y., Norris, J. D., Grøn, H., Paige, L. A., Hamilton, P. T., Kenan, D. J., Fowlkes, D., & McDonnell, D. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8226 · Cited by 364
Self-citationAnatomy of the estrogen response element
Gruber, C. J., Gruber, D. M., Gruber, I. M. L., Wieser, F., & Huber, J. C. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.01.008 · Cited by 319
Barreto, V., Reina-San-Martin, B., Ramiro, A. R., McBride, K. M., & Nussenzweig, M. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00309-5 · Cited by 269
Hall, J. M. (2002) · Molecular Endocrinology · doi:10.1210/me.16.3.469 · Cited by 253
Suen, C.-S., Berrodin, T. J., Mastroeni, R., Cheskis, B. J., Lyttle, C. R., & Frail, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27645 · Cited by 252
Leduc, A.-M., Trent, J. O., Wittliff, J. L., Bramlett, K. S., Briggs, S. L., Chirgadze, N. Y., Wang, Y., Burris, T. P., & Spatola, A. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934759100 · Cited by 222
Modulation of Estrogen Receptor-α Transcriptional Activity by the Coactivator PGC-1
Tcherepanova, I., Puigserver, P., Norris, J. D., Spiegelman, B. M., & McDonnell, D. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001364200 · Cited by 217
Self-citationHanda, R. J., Pak, T. R., Kudwa, A. E., Lund, T. D., & Hinds, L. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.09.012 · Cited by 205
“Of these, glucocorticoid receptor interacting protein 1 (GRIP1; also called SRC-2, TIF2, and NCoA2) has been shown to be an important regulator of ER signaling (Hong et al., 1996; Norris et al., 1998).”
BackgroundKlinge, C. M., Jernigan, S. C., Mattingly, K. A., Risinger, K. E., & Zhang, J. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01541 · Cited by 197
“…used in transfection experiments are from the complement C3, transforming growth factor- 3, and lactoferrin gene promoters that were used to examine the functional interaction of ER with the receptor of estrogen receptor activity (Delage-Mourroux et al. 2000) and SRC-2/GRIP1 (Norris et al. 1998).”
BackgroundMethodInfluentialJohansson, L., Thomsen, J. S., Damdimopoulos, A. E., Spyrou, G., Gustafsson, J.-Å., & Treuter, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.345 · Cited by 184
Chapter 8: Estrogen Receptor-Mediated Processes in Normal and Cancer Cells
Dickson, R. B., & Stancel, G. M. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024237 · Cited by 168
“To investigate this possibility, Dr. McDonnell’s laboratory performed a series of studies in which they co-transfected one such coactivator (termed GRIP) into cells along with either the wild-type or mutated ER ( 25 ).”
BackgroundPak, T. R., Chung, W. C. J., Hinds, L. R., & Handa, R. J. (2007) · Endocrinology · doi:10.1210/en.2007-0086 · Cited by 69
Oxytocin, vasopressin and their interplay with gonadal steroids
Dhakar, M. B., Stevenson, E. L., & Caldwell, H. K. (2013) · Oxytocin, Vasopressin and Related Peptides in the Regulation of Behavior · doi:10.1017/cbo9781139017855.003 · Cited by 20
Metadata
- Authors
- Norris, J. D., Fan, D., Stallcup, M. R., & McDonnell, D. P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-03
- Volume
- 273
- Issue
- 12
- Pages
- 6679-6688
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1986578326
- Cited by
- 97
- References
- 3
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.